Inappropriate use of inhaled short acting beta-agonists and its association with patient health status

References

• National Heart, Lung and Blood Institute. The NAEPP expert panel report: guidelines for the diagnosis and management of asthma – update on selected topics 2002. NIH: Bethesda, MD
   Google Scholar
• Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3–8
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma-expert panel report 2, 1997. NIH: Bethesda, MD
   Google Scholar
• Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98:1016–8
   PubMed Web of Science ®Google Scholar
• MacKinnon NJ, Flagstad MS, Peterson CR, et al. Disease management program for asthma: baseline assessment of resource use. Am J Health Syst Pharm 1996;53:535–41
   PubMed Web of Science ®Google Scholar
• Vathenen AS, Knox AJ, Higgins BG, et al. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;1:554–8
   PubMed Web of Science ®Google Scholar
• Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336: 1391–6
   PubMed Web of Science ®Google Scholar
• Sears MR, Rea HH, Fenwick J, et al. 75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) 1987;294: 477–80
   PubMed Web of Science ®Google Scholar
• Taylor DR, Sears MR, Cockcroft DW. The beta-agonist controversy [review]. Med Clin North Am 1996;80:719–48
   PubMed Web of Science ®Google Scholar
• Walsh LJ, Wong CA, Cooper S, et al. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999;54:296–300
   PubMed Web of Science ®Google Scholar
• Anis AH, Lynd LD, Wang XH, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625–31
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma control with health care utilization. Am J Respir Crit Care Med 2002;165:195–99
   PubMed Web of Science ®Google Scholar
• Roberts J, Williams A. Quality-of-life and asthma control with low-dose inhaled corticosteroids. Brit J Nurs 2004;13:1124–9
   PubMedGoogle Scholar
• Thoonen BP, Schermer TR, Van Den BG, et al. Self-management of asthma in general practice, asthma control and quality of life: A randomized controlled trial. Thorax 2003;58:30–6
   PubMed Web of Science ®Google Scholar
• Ehrs PO, Aberg H, Larsson K. Quality of life in primary care asthma. Respir Med 2001;95:22–30
   Google Scholar
• Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999;160:1647–52
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. ‘What is MEPS?’ Rockville, MD: AHRQ, 2001. Available from http://www.meps.ahrq.gov/whatis.htm [Accessed March 1 2001]
   Google Scholar
• Agency for Healthcare Research and Quality. MEPS HC-052: 2000 medical conditions file. Rockville, MD: AHRQ 2003;1–25
   Google Scholar
• Multum Lexicon (Drug Database). Denver, CO: Cerner Multum, Inc. 2002. Available from http://www.multum.com/Lexicon.htm [Accessed March 15 2003]
   Google Scholar
• World Health Organization collaborating center for drug statistics methodology. ATC classification index with DDDs, 2003; Oslo, Norway: WHO
   Google Scholar
• D’Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Meth Info Med 1993;32:382–7
   Google Scholar
• SAS Systems for Window (Statistical Software). Cary, NC: SAS Institute, Inc. 2004
   Google Scholar
• Burney P, Chinn S, Luczynska C, et al. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European community respiratory health survey (ECRHS). Eur Respir J 1996;9:687–95
   PubMed Web of Science ®Google Scholar
• Rickard KA, Stempel DA. Asthma survey demonstrates that the goals of the NHLB1 have not been accomplished. J Allergy Clin Immunol 1999;103:S171
   Web of Science ®Google Scholar
• Vermeire P. Differences in asthma management around the world. Eur Respir Rev 1994;4:279–81
   Google Scholar
• Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142–9
   PubMed Web of Science ®Google Scholar
• Erickson SR, Coombs JH, Kirking DM, et al. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Annal Pharmacother 2001;35:997–1003
   PubMed Web of Science ®Google Scholar
• Bruyere Jr H, Culver BW. Pathophysiology and treatment of asthma. Pharm Times 2001;67:62–72
   Google Scholar
• Barbanel D, Eldridge S, Griffiths C. Can a self-management program delivered by a community pharmacist improve asthma control? A randomized controlled trial. Thorax 2003;58:851–4
   Google Scholar